Funapide

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameFunapide
Drug Alias Name呋纳匹特funapide夫那匹德funapidumfunapida +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit blockersSodium channel protein type IX alpha subunit blockers
TargetsSodium channel protein type IX alpha subunitSodium channel protein type X alpha subunit
Therapy Area/IndicationsPain, PostoperativeErythromelalgiaNeuralgia, Postherpetic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesXenon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPacira Biosciences IncPacira Pharmaceuticals IncFlexion Therapeutics Inc
Inactive CompaniesTeva Branded Pharmaceutical Products R&D IncXenon Pharmaceuticals Inc
Active IndicationsPain, PostoperativeBunion
Inactive IndicationsErythromelalgiaNeuralgia, PostherpeticToothache +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia